Over the years I’ve often written about how unlicensed stem cell clinics and their physicians are putting patients at risk. In most if not all cases they are doing this simply for their own personal monetary gain. I do think that some of them truly believe they are helping patients, but still that doesn’t excuse […]
10 ways non-compliant stem cell clinic docs jeopardize their careers Read More »
When I started blogging in 2010 the stem cell arena was a very different place including the fact I could count the number of US stem cell clinics on one hand. This blog, called The Niche for many years, was just “Knoepfler Stem Cell Blog” back then. Also, back then the hot topic was the
Stem cell clinics, FDA, & giant, unapproved for-profit human experiments Read More »
The Texas stem cell clinic Celltex was one of the most controversial businesses in the world of stem cells in 2012 and 2013 (see here for background and as an update see this new post on how the Texas clinic has teamed up with a local university). The FDA essentially shut down the Celltex clinical
Arthritis Foundation Sell Out To Stem Cell Clinic Celltex? Read More »
Who is Doug Broeska and what is Regenetek a Canadian stem cell company doing that is drawing attention of authorities? The Winnipeg Free Press is reporting that Regenetek faces serious charges related to for-profit stem cell therapies. (Update: a followup story in the Free Press has been published). A very thorough article in the newspaper
Stem cell clinic & Doug Broeska face stem cell fraud allegations Read More »
Is it the beginning of the end for dubious American clinics that sell transplants of unproven and non-FDA approved fat stem cell injections? As the year of 2014 was winding down, the FDA issued two key new draft guidances (see here and here) that could prove to be crash diets for these burgeoning fat stem cell clinics. (Update: As of
FDA to Put Mushrooming Fat Stem Cell Clinics on Crash Diet? Read More »
Change is in the air for the California stem cell agency, CIRM. It has a new President, Randy Mills, and CIRM is soon going to be like a new agency too. I recently did an interview with Mills that illuminates some of the big changes that are imminent. I also asked him what his favorite
Radical Vision for CIRM Future: Interview with New Prez Mills Read More »
It’s hard to even imagine the world of investigative medicine without the wonderful resource of Clinicaltrials.gov, the global hub for clinical trial listings. I recently interviewed the Director of Clinicaltrials.gov, Dr. Deborah Zarin here, which is a fascinating read. As great as Clinicaltrials.gov is as a resource, unfortunately it faces a new, rapidly growing problem that is a serious
Clinicaltrials.gov Mission At Risk From Proliferating For-Profit Trials Read More »
They say a little knowledge is a dangerous thing and more specifically I say that a little stem cell training for MDs, such as from A4M, can potentially be a dangerous problem too. I’ve been very concerned about self-proclaimed “stem cell training courses” for MDs. These kinds of courses have claimed that over as short as a
Will Speedy A4M Stem Cell Course for Docs Put Patients at Risk? Read More »
The Alabama Institute of Medicine (AIM) is one of the great success stories in the stem cell research field. It’s an extraordinary achievement as a state stem cell agency. Below I’ve interviewed one of AIM’s founders and its Vice President, Tory Williams. Above you can see a picture of Tory with Roman Reed at the
Interview with Tory Williams of Amazing Alabama Institute of Medicine (AIM) Read More »
What’s the deal with this week’s FDA Warning Letter to 23andMe? First some background. I’m a researcher who studies stem and cancer cell genomics and epigenomics. I’m also a human being who has battled prostate cancer and is curious about my genome. With this background, I decided some time ago to take the plunge and experience what
23andMe and the FDA: Perspectives on Warning Letter Read More »